ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,633.09
0.13%
US Tech 100
19,020.40
0.48%
Dow Jones
41,622.08
0.55%
Brent Oil
72.12
-0.68%
Bitcoin
58,846.97
1.14%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Clene Inc (CLNN) Quote

Clene Inc

Clene Inc (CLNN)

NASDAQ
5.59
-1.15
(-17.06%)
Closed September 16 4:00PM
Delayed by 15 minutes
5.59
0.00
( 0.00% )
Pre Market: 4:15AM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
5.59
Bid
5.66
Ask
6.23
Volume
-
0.00 Day's Range 0.00
3.8181 52 Week Range 13.20
Market Cap
36.168M
Previous Close
5.59
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
238,940
Shares Outstanding
6,470,067
Dividend Yield
-
PE Ratio
-0.73
Earnings Per Share (EPS)
-7.65
Revenue
654k
Net Profit
-49.5M

About Clene Inc

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development a... Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development and commercialization of novel clean-surfaced nanotechnology therapeutics (Drugs, and (2) the development and commercialization of dietary supplements (Supplements). Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.clene.com
Headquarters
Dover, Delaware, USA
Founded
-
Clene Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CLNN. The last closing price for Clene was $5.59. Over the last year, Clene shares have traded in a share price range of $ 3.8181 to $ 13.20.

Clene currently has 6,470,067 shares outstanding. The market capitalization of Clene is $36.17 million. Clene has a price to earnings ratio (PE ratio) of -0.73.

Ask ADVFN Intelligence (AI)

CLNN Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities

August 19 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

August 19 2024
Edgar (US Regulatory)

IBN Announces Latest Episode of The BioMedWire Podcast featuring Rob Etherington, CEO of Clene Inc.

LOS ANGELES, Aug. 08, 2024 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to...

August 08 2024
GlobeNewswire Inc.

Form 8-K - Current report

August 07 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

August 07 2024
Edgar (US Regulatory)

Form 8-K - Current report

August 06 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

July 30 2024
Edgar (US Regulatory)

Form 8-K - Current report

July 26 2024
Edgar (US Regulatory)

Form 8-K - Current report

July 11 2024
Edgar (US Regulatory)

Form 8-K - Current report

July 09 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.41-6.8333333333366.835.5806075.89230178CS
40.254.681647940075.346.95.0275752975.85494458CS
12-2.076-27.08061570577.6667.83.81812389405.83205516CS
26-2.41-30.12589.23.81815584756.98366209CS
52-5.986-51.710435383611.57613.23.81816665317.66627159CS
156-151.21-96.4349489796156.81623.818155067533.01916195CS
260-185.41-97.0732984293191356.43.818149962754.6656124CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
GLMDGalmed Pharmaceuticals Ltd
$ 6.65
(71.83%)
2.13M
SMSISmith Micro Software Inc
$ 0.854
(63.29%)
5.87M
WHLRWheeler Real Estate Investment Trust Inc
$ 10.03
(36.46%)
1.15M
ATGLAlpha Technology Group Limited
$ 1.77
(28.26%)
1
BDSXBiodesix Inc
$ 2.27
(26.82%)
10
NCPLNetcapital Inc
$ 2.00
(-30.56%)
9.54k
NKGNNKGen Biotech Inc
$ 0.6003
(-19.42%)
980
RMCFRocky Mountain Chocolate Factory Inc
$ 1.46
(-17.51%)
1
DRMADermata Therapeutics Inc
$ 2.00
(-13.79%)
74.47k
GDHGGolden Heaven Group Holdings Ltd
$ 0.0916
(-12.76%)
84.15k
SMSISmith Micro Software Inc
$ 0.854
(63.29%)
5.87M
GLMDGalmed Pharmaceuticals Ltd
$ 6.65
(71.83%)
2.13M
SPRCSciSparc Ltd
$ 0.3442
(10.46%)
1.38M
WHLRWheeler Real Estate Investment Trust Inc
$ 10.03
(36.46%)
1.15M
INTCIntel Corporation
$ 22.31
(6.70%)
1.05M

CLNN Discussion

View Posts
Awl416 Awl416 1 month ago
Damn
👍️0
Termite7 Termite7 4 months ago
Lower please.....thanks!!!
👍️0
Awl416 Awl416 5 months ago
Pop
👍️0
Monksdream Monksdream 6 months ago
CLNN 10Q due March 8
👍️0
Monksdream Monksdream 9 months ago
CLNN new 52 week low
👎️ 1 🩳 1
scotsand scotsand 9 months ago
Running now. Join the fun.
👍️0
Monksdream Monksdream 11 months ago
CLNN new 52 week low
👍️0
Monksdream Monksdream 12 months ago
CLNN new 52 week low
👍️0
Monksdream Monksdream 1 year ago
CLNN new 52 week low
👍️0
Monksdream Monksdream 1 year ago
CLNN new 52 week low
👍️0
Louman Louman 1 year ago
7 analyst ratings still 100% buy. PT $4-$10.
👍️0
Louman Louman 1 year ago
$3.4 million in inside buys between 6-20 and 6-27. Price target $5. 7 analyst ratings 100% buy
👍️0
bwrbad bwrbad 1 year ago
THIS IS ONE ISSUE DO NOT MISS
👍️0
JUST 10-11-12 JUST 10-11-12 2 years ago
i.ll take 12 bucks per share
👍️0
CapGainsman CapGainsman 2 years ago
EF Hutton initiates coverage today on CLNN with a $13 price target. And HC Wainwright has reiterated a $15 price target twice in recent days. And CLNN has reported positive trial results in recent weeks. Other than there appear to be a bunch of pesky shorters involved, this seems like a gift down here. Also, CLNN will be presenting in the upcoming Roth's 35th annual healthcare conference.
👍️0
81vette 81vette 2 years ago
12mms stacked,bid/demand growing,13k@1.21,could pop any min now
👍️0
81vette 81vette 2 years ago
Over 3m shares short,some covering has to happen
👍️0
81vette 81vette 2 years ago
Day1 of higher high/higher low,gotta love nabbing the very beginning of bulls being turned loose,market is manipulated the worst in 20 years,mms/banks have gotten ridiculously greedy,can’t beat em/join um is my motto
👍️0
81vette 81vette 2 years ago
My Scanner telling me buy now,bulls back to loading for run again
👍️0
skichic skichic 2 years ago
Oppenheimer has a buy rating of Overweight for CLNN and a price target of $20.00!
👍️0
skichic skichic 2 years ago
Strange how CLNN traded today. Fantastic news, huge insider buy and the shorts controlled. Absolutely crazy. I added to my stash big time!
👍️0
81vette 81vette 2 years ago
Bills have to get paid,maybe done in after mkt for continued this year long up trend,
👍️0
TheFinalCD TheFinalCD 2 years ago
ALL DAY FADER= ZZZZZZZZZ
👍️0
81vette 81vette 2 years ago
todays news>https://capedge.com/news/benzinga/30873738/clene-reports-new-data?fromCompany=1822791
👍️0
81vette 81vette 2 years ago
zero borrow>no shares available to short(float locked up),insider buys up 400%,recient news coverage blowing up,283Xs ave vol will get attention today
👍️0
81vette 81vette 2 years ago
#1 on my scanner>Strong Volume Gainer,New CCI Buy Signals,Parabolic SAR Buy Signals,Gap Ups,Filled Black Candles,Elder Bar Turned Green
👍️0
81vette 81vette 2 years ago
#1 on my scanner>Strong Volume Gainer,New CCI Buy Signals,Parabolic SAR Buy Signals,Gap Ups,Filled Black Candles,Elder Bar Turned Green
👍️0
81vette 81vette 2 years ago
Shares Outstanding 63.51M,Shares Float 27.20M,Institutional Ownership 6.00%,Insider Ownership 8.80%,Short Float 6.74%
👍️0
harry crumb harry crumb 2 years ago
Any reason this is active other than form 4’s filed? Their lead science candidate failed
👍️0
tw0122 tw0122 2 years ago
At least you got the board opened flipped it once already when it went under $2 $1.95 to $2.17. Maybe will try one more time on a pullback..
👍️0
TheFinalCD TheFinalCD 2 years ago
https://clene.com/pipeline/
👍️0
TheFinalCD TheFinalCD 2 years ago
https://finviz.com/quote.ashx?t=CLNN&ty=c&ta=1&p=d
👍️0

Your Recent History

NASDAQ
CLNN
Clene
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved